Serotonergic psychedelic treatment for obesity and eating disorders: potential expectations and caveats for emerging studies
Stephanie L. Borgland, Drew M. Neyens
Journal of Psychiatry and Neuroscience June 1, 2022 DOI: 10.1503/jpn.220090 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Depression LSD Serotonin |
| Keywords | Hallucinogen Clinical trial Eating disorders |
| Citations | 14 |
| Key points | There has been substantial growth in private clinics and registered clinical trials employing serotonergic psychedelics for psychiatric illnesses including substance use disorder and major depressive disorder. |
Abstract
There has been a substantial growth in private clinics and registered clinical trials employing serotonergic psychedelics for various psychiatric illnesses, including substance use disorder[1][1],[2][2] and major depressive disorder.[3][3]–[6][4] Classical psychedelics include lysergic acid
Citations in the library
Cited by 12
- Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms European Neuropsychopharmacology June 21, 2023
- Psychedelics and the treatment of eating disorders: considerations for future research and practice. Journal of Eating Disorders October 22, 2024
- History, Hype, and Responsible Psychedelic Medicine: A Qualitative Study of Psychedelic Researchers. Journal of Bioethical Inquiry October 4, 2024
- The Role of Music in Psychedelic-Assisted Therapy: A Comparative Analysis of Neuroscientific Research, Indigenous Entheogenic Ritual, and Contemporary Care Models. Psychedelic Medicine December 2, 2024
- Emerging Interventions in Behavioral Addictions: A Narrative Review of Psychedelics and Neuromodulation. Brain Sciences September 12, 2025
and 7 more in the library
Cites 30
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
and 25 more in the library